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The Power of Genetic Analysis to Explain Divergent Clinical and Pathologic Features of
Mechanobullous Disease
One of the frustrations of the clinician occurs when the clinical and
pathologic findings conflict. In a study (p. 744) from Giovanna
Zambruno’s laboratory in Rome, genetic analysis of an Italian family
with three affected siblings was able to detect mutations when
immunofluorescent antigen mapping and ultrastructure were normal.
The family had a mild mechanobullous disease with onset in infancy,
but blistering localized to hands, feet, elbows, and knees. A dystrophic
form of epidermolysis bullosa (EB) was suspected because of some
milia and scarring; however, antigen mapping showed the presence of
abundant type VII collagen, and electron microscopy demonstrated
numerous anchoring fibrils of normal length and thickness and a cross-
banding pattern. Normal collagen VII RNA was found; then the
EB Simplex Subtypes: Distinct Genetic Diseases?
There are three recognized types of EB simplex: the Weber–Cockayne
type with blisters mostly limited to hands and feet; the Koebner type
with mild, but generalized blistering; and the Dowling–Meara type,
with severe widespread cutaneous erosions, oral lesions, nail involve-
ment, and palmoplantar hyperkeratosis. All three types demonstrate
mutations in the genes that encode the paired keratins, keratin 5 and
keratin 14. Recent reports have emphasized how the mutations in
those positions of the gene encoding the ends of the central rod
domain, the helix initiation sites, or termination sites of either gene
were associated with the severe phenotype. Mutation location was used
to predict severity and was becoming a standard for genotype:phenotype
correlations. Unfortunately, it may not be so easy. In the paper by
Carrie Shemanko (p. 893), working with Birgitte Lane in Dundee and
Robin Eady in London, a patient with the severe Dowling–Meara
The Accessory Keratin Gene 2e and the Bullous Ichthyoses
The major keratins are expressed in pairs, yet in certain situations access-
ory keratins are expressed. This is true of keratin 2e, seen in the suprabasi-
lar layers of epidermis. Keratin 2 molecules are found both in epidermis
and in the hard palate and are designated 2e or 2p. Although structurally
similar, they are encoded by separate genes. Mutations in the gene
encoding keratin 2e have recently been correlated with a phenotype
characterized by superficial blistering of skin and a mild hyperkeratosis.
This is in contrast to the severe bullous ichthyosis called epidermolytic
hyperkeratosis, previously reported to result from mutations in the gene
encoding keratins 1 or 10. In a manuscript by W.H. Irwin McLean (p.
817) working in the laboratory of Juoni Uitto in Philadelphia, the authors
determined the genomic structure of the keratin 2e gene by direct
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entire collagen VII gene was scanned by polymerase chain reaction
amplification followed by heteroduplex analysis of the entire family.
The affected siblings were heterozygous for two unique mutations, a
glycine substitution at G1347R and a splice site mutation 5820G-A.
Thus, this is a recessive dystrophic form of EB, albeit an exceptionally
mild form. It is interesting that these mutations allow synthesis,
secretion, and deposition of stable collagen VII and the supramolecular
assembly of collagen VII molecules into anchoring fibrils, such that
standard pathology detection methods do not detect any abnormalities.
The mild collagen VII functional defect only occurs in skin areas of
excessive friction.
type of EB simplex demonstrates mutations at the same site (M119 of
the keratin 14 gene) as previously reported individuals with the
Koebner or Weber–Cockayne subtypes. In this paper the patient
affected with the severe Dowling–Meara subtype was found to have a
methionine to threonine amino acid change at position 119. Previous
reports have found a methionine to isoleucine change at position 119
resulted in the mild Weber–Cockayne subtype or two mutated alleles
with the methionine to isoleucine change resulted in the Koebner
subtype. Thus, mutations at the same site may result in all three
subtypes. The authors warn not to assume a simple relationship between
gene mutation site and phenotype. Rather, it may be that the differences
between the subtypes of EB simplex may not represent distinct genetic
conditions, but differences in severity.
sequencing and used this information to analyze two British families with
keratin 2e mutations. In one family, the same mutation produced two
distinct phenotypes with one affected individual having mild superficial
erosions and another having severe epidermolytic hyperkeratosis, sug-
gesting that other genetic factors contribute to the phenotype. This
laboratory had previously described similar variations in families with K1
mutations, which is thought to be responsible for classic epidermolytic
hyperkeratosis and in pachyonychia congenita type 2. If a keratin 1 or 10
mutation is not detected in epidermolytic hyperkeratosis, then keratin
2e should be examined. It is now possible to search the entire keratin 2e
gene for mutations that will facilitate examination of other families for
new mutations.
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Pemphigus, Lymphoproliferative Disorders, and HHV-8
When does a negative study become a positive? A study from the
NIH (p. 781) in this issue provides a good example. It is known that
paraneoplastic pemphigus is associated with a rare lymphoproliferative
disorder (Castleman’s Disease). The B lymphocyte proliferation in
Castleman’s disease is believed to be the source of the pemphigus
autoantibodies in paraneoplastic pemphigus. Castleman’s disease has
recently been linked with HHV-8 infection (.90% of patients), as
have patients with primary effusion lymphoma. Sandra Cohen working
in the laboratory of Andrew Blauvelt at the NIH reasoned that as both
HHV-8 infection and paraneoplastic pemphigus were highly associated
with Castleman’s disease, then HHV-8 might be related to paraneoplastic
pemphigus. With the assistance of Grant Anhalt at Johns Hopkins
University, a world’s authority on paraneoplastic pemphigus, they
examined 25 patients with paraneoplastic pemphigus (10 with associated
Castleman’s disease) and 19 with pemphigus vulgaris. Using careful
controls, an immunofluorescent anti-HHV-8 antibody serum assay and
a nested polymerase chain reaction examination of frozen lesional skin
for HHV-8 DNA was used. Kaposi’s sarcoma patients as positive
controls were all positive by both assays, but all forms of pemphigus
and otherwise healthy subjects were negative. This study contradicts
earlier reports by Memar et al (J Invest Dermatol 108:118, 1997; Arch
Dermatol 133:1247, 1997) that found HHV-8 DNA sequences in
pemphigus vulgaris and pemphigus foliaceous. The authors speculate
that potential contamination in the sensitive polymerase chain reaction
assay may explain the differences observed. This paper would indicate
that autoantibody production in paraneoplastic pemphigus may not be
induced by HHV-8, but other infectious agents have not been excluded.
